Analysis on the risks of severe adverse events in rabies post-exposure prophylaxis and appropriate decision-making procedure

References

• Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, et al. Estimating the global burden of endemic canine rabies. Plos Neglect Trop D. 2015;9(4):e0003709. doi:10.1371/journal.pntd.0003709.
   PubMed Web of Science ®Google Scholar
• Tao X, Tang Q, Rayner S, Guo Z, Li H, Lang S, Yin C, Han N, Fang W, Adams J, et al. Molecular phylodynamic analysis indicates lineage displacement occurred in Chinese rabies epidemics between 1949 to 2010. Plos Neglect Trop D. 2013;7(7):e2294. doi:10.1371/journal.pntd.0002294.
   PubMed Web of Science ®Google Scholar
• Wilde H. Failures of post-exposure rabies prophylaxis. Vaccine. 2007;25(44):7605–7609. doi:10.1016/j.vaccine.2007.08.054.
   PubMed Web of Science ®Google Scholar
• Moro PL, Woo EJ, Paul W, Lewis P, Petersen BW, Cano M. Post-marketing surveillance of human rabies diploid cell vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015. Plos Neglect Trop D. 2016;10(7):e0004846. doi:10.1371/journal.pntd.0004846.
   PubMed Web of Science ®Google Scholar
• Singh AK, Wagner AL, Joshi J, Carlson BF, Aneja S, Boulton ML. Application of the revised WHO causality assessment protocol for adverse events following immunization in India. Vaccine. 2017;35(33):4197–4202. doi:10.1016/j.vaccine.2017.06.027.
   PubMed Web of Science ®Google Scholar
• Beckham JM, Noroski L, McNeil JC. Immediate hypersensitivity reaction related torabiespost-exposure-prophylaxis in thailand with subsequent rabies vaccine change to avoid polygeline vaccine excipient with successful challenge and treatment tolerance in the United States. Open Forum Infect Dis. 2017;4(Suppl 1):S124–S125. doi:10.1093/ofid/ofx163.164.
   Google Scholar
• World Health Organization. WHO expert consultation on rabies: third report. WHO press; 2018.
   Google Scholar
• World Health Organization. WHO expert consultation on rabies. Second report. World Health Organ Tech Rep. 2013;982(982):1–139.
   Google Scholar
• de Silva R, Dasanayake WMDK, Wickramasinhe GD, Karunatilake C, Weerasinghe N, Gunasekera P, Malavige GN. Sensitization to bovine serum albumin as a possible cause of allergic reactions to vaccines. Vaccine. 2017;35(11):1494–1500. doi:10.1016/j.vaccine.2017.02.009.
   PubMed Web of Science ®Google Scholar
• Jackson AC. Human rabies: a 2016 update. Curr Infect Dis Rep. 2016;18(11):38. doi:10.1007/s11908-016-0540-y.
   PubMed Web of Science ®Google Scholar
• Peng J, Lu S, Zhu Z, Zhang M, Hu Q, Fang Y. Safety comparison of four types of rabies vaccines in patients with WHO category II animal exposure. Medicine. 2016;95(47):e5049. doi:10.1097/MD.0000000000004864.
   PubMed Web of Science ®Google Scholar
• Yu P, Huang Y, Zhang Y, Tang Q, Liang G. Production and evaluation of a chromatographically purified Vero cell rabies vaccine (PVRV) in China using microcarrier technology. Hum Vacc Immunother. 2014;8(9):1230–1235. doi:10.4161/hv.20985.
   Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing: China Medical Science and Technology Press; 2010.
   Google Scholar
• Fang Y, Chen L, Liu M, Zhu Z, Zhu Z, Hu Q. Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO Category II animal exposure: A study based on different age groups. Plos Neglect Trop D. 2014;8(12):e3412. doi:10.1371/journal.pntd.0003412.
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett S, Levis R, Meltzer MI, Schaffner W, et al. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine. 2009;27(51):7141–7148. doi:10.1016/j.vaccine.2009.09.029.
   PubMed Web of Science ®Google Scholar
• Shi N, Zhang Y, Zheng H, Zhu Z, Wang D, Li S, Li Y, Yang L, Zhang J, Bai Y, et al. Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects. Hum Vacc Immunother. 2017;13(6):1338–1345. doi:10.1080/21645515.2017.1279770.
   PubMed Web of Science ®Google Scholar
• Peng J, Chen L, Zhu Z, Zhu Z, Hu Q, Fang Y. Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG. Hum Vacc Immunother. 2014;10(12):3622–3626. doi:10.4161/21645515.2014.979621.
   PubMed Web of Science ®Google Scholar
• Sari T, Tulek N, Bulut C, Oral B, Tuncer Ertem G. Adverse events following rabies post-exposure prophylaxis: A comparative study of two different schedules and two vaccines. Travel Med Infect Di. 2014;12(6,Part A):659–666. doi:10.1016/j.tmaid.2014.03.004.
   PubMed Web of Science ®Google Scholar
• Fang Y, Liu M, Chen L, Zhu Z, Zhu Z, Hu Q. Rabies post-exposure prophylaxis for a child with severe allergic reaction to rabies vaccine. Hum Vacc Immunother. 2016;12(7):1802–1804.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zheng Y, Lu S, Hu Q, Fang Y. Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination. Hum Vacc Immunother. 2018:1–3.
   PubMed Web of Science ®Google Scholar
• Franceschini F, Bottau P, Caimmi S, Crisafulli G, Lucia L, Peroni D, Saretta F, Vernich M, Povesi Dascola C, Caffarelli C. Vaccination in children with allergy to non active vaccine components. Clin Transl Med. 2015;4:1. doi:10.1186/s40169-014-0043-0.
   PubMed Web of Science ®Google Scholar
• Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, Caubet J, Engler RJM, Gold MS, Ponvert C, et al. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J. 2016;9:1. doi:10.1186/s40413-016-0118-z.
   PubMed Web of Science ®Google Scholar
• Hu Q, Liu M, Zhu Z, Zhu Z, Lu S. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hum Vacc Immunother. 2014;10(6):1645–1649. doi:10.4161/hv.28420.
   PubMed Web of Science ®Google Scholar
• Hee CE. Vaccine allergies. Clin Exp Vaccine Res. 2014;3(1):50–57. doi:10.7774/cevr.2014.3.1.50.
   PubMedGoogle Scholar